Cooley LLP demonstrates strength through its leadership on major cross-border capital markets transactions, advising high-growth companies – and their underwriters – on complex global offerings, particularly standing out as a leader in cross-border US IPOs for European companies. In San Diego, co-head Charlie Kim handles equity and debt transactions for prominent domestic and international issuers in healthcare, technology, and consumer sectors and is trusted by major investment banks. In San Francisco, co-head David Peinsipp advises globally recognized tech and tech-enabled companies on going-public transactions and other high-impact capital-raising offerings. Also in San Francisco, Kristin VanderPas handles IPOs, follow-ons, and de-SPACs, while Denny Won focuses on high-yield, investment-grade, and convertible debt. In New York, Div Gupta advises clients in healthcare and life sciences, and Richard Segal works across technology, consumer, and retail sectors. In Boston, Marc Recht handles complex corporate and securities matters, including IPOs, focusing on life sciences clients, and Courtney Thorne is skilled in foreign private issuer matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Exceptional team.'
- ‘Div Gupta is the great partner who coordinates all legal matters. Fantastic support.'
- 'We always felt well supported by the Cooley team at all times. The Cooley team generally offered practical solutions (not just the legal textbook answer) and guidance for making the solution work in the real world.'
Key clients
- Life360
- WeRide
- Abivax
- Yueda Digital Holding
- ZOOZ Power
- Inventiva SA
- Bitdeer Technologies Holding Company
- Valneva
- Oculis Holding AG
- RBC Dominion Securities Inc.
- Alvotech
- Canaan
Work highlights
Advised Abivax on its $747.5 million follow-on offering of 18,699,460 American depositary shares at a public offering price of $11.60 per ADS in the US and a concurrent offering of 1,626,040 ordinary shares to certain investors in certain jurisdictions outside the US.
Advised the underwriters in NewAmsterdam Pharma’s $479 million follow-on offering of (i) 14,667,347 ordinary shares at a public offering price of $24.50 per ordinary share and (ii) pre-funded warrants to purchase 4,882,653 ordinary shares at a public offering price of $24.4999 per pre-funded warrant.
Advised ZOOZ Power on its Securities Purchase Agreements for an aggregate of up to $180 million private placement of ordinary shares, warrants, and pre-funded warrants pursuant to two separate securities purchase agreements.
Practice head
Charlie Kim; David Peinsipp
Other key lawyers
Kristin VanderPas; Denny Won; Div Gupta; Richard Segal; Marc Recht; Courtney Thorne